Disturbances across whole brain networks during reward anticipation in an abstinent addiction population. by Nestor, Liam J et al.
Contents lists available at ScienceDirect
NeuroImage: Clinical
journal homepage: www.elsevier.com/locate/ynicl
Disturbances across whole brain networks during reward anticipation in an
abstinent addiction population
Liam J. Nestora,b, John Sucklingb, Karen D. Erscheb,d, Anna Murphyc, John McGoniglea,
Csaba Orbana, Louise M. Patersona, Laurence Reeda, Eleanor Taylorc, Remy Flechaisa,
Dana Smithb,d, Edward T. Bullmoreb, Rebecca Elliottc, Bill Deakinc, Ilan Rabinere,
Anne-Lingford Hughesa, Barbara J. Sahakianb, Trevor W. Robbinsb,d, David J. Nutta, ICCAM
Consortium
aNeuropsychopharmacology Unit, Centre for Psychiatry, Imperial College London, United Kingdom
bDepartment of Psychiatry, University of Cambridge, United Kingdom
dDepartment of Psychology, University of Cambridge, United Kingdom
cNeuroscience and Psychiatry Unit, University of Manchester, United Kingdom
e Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
A B S T R A C T
The prevalent spatial distribution of abnormalities reported in cognitive fMRI studies in addiction suggests there are extensive disruptions across whole brain
networks. Studies using resting state have reported disruptions in network connectivity in addiction, but these studies have not revealed characteristics of network
functioning during critical psychological processes that are disrupted in addiction populations. Analytic methods that can capture key features of whole brain
networks during psychological processes may be more sensitive in revealing additional and widespread neural disturbances in addiction, that are the provisions for
relapse risk, and targets for medication development. The current study compared a substance addiction (ADD; n = 83) group in extended abstinence with a control
(CON; n = 68) group on functional MRI (voxel-wise activation) and global network (connectivity) measures related to reward anticipation on a monetary incentive
delay task. In the absence of group differences on MID performance, the ADD group showed reduced activation predominantly across temporal and visual regions, but
not across the striatum. The ADD group also showed disruptions in global network connectivity (lower clustering coefficient and higher characteristic path length),
and significantly less connectivity across a sub-network comprising frontal, temporal, limbic and striatal nodes. These results show that an addiction group in
extended abstinence exhibit localised disruptions in brain activation, but more extensive disturbances in functional connectivity across whole brain networks. We
propose that measures of global network functioning may be more sensitive in highlighting latent and more widespread neural disruptions during critical psycho-
logical processes in addiction and other psychiatric disorders.
1. Introduction
Reward processing is a psychological construct that has evolved to
drive incentive-based learning and the development of goal-directed
behaviours in humans. Reward processing is mediated by a collection of
subcortical and prefrontal cortical regions (Haber and Knutson, 2010;
Knutson et al., 2001; O'Doherty et al., 2001) that are connected to form
a complex neural network encoding various types of rewarding stimuli
(Belin and Everitt, 2008; Draganski et al., 2008; Haber and Knutson,
2010). Substance addiction disorders are associated with disturbances
within this reward network during the processing of non-drug rewards
(Balodis and Potenza, 2015; Hommer et al., 2011; Just et al., 2019;
Koob and Le Moal, 2005; Luijten et al., 2017; Wrase et al., 2007), and
which are associated with drug relapse during abstinence (Gowin et al.,
2015; Stewart et al., 2014). Most studies in addiction populations,
however, only probe regional differences in brain functioning, and do
not attempt to elucidate features of global connectivity across networks
that respond during certain psychological processes, such as reward.
Differences in global network connectivity likely underlie the regional
differences commonly reported in functional MRI studies in addiction
disorders, and therefore, may be more sensitive in revealing widespread
neural disturbances in addiction disorders.
Connectivity across brain networks can be probed by examining
various characteristics that relate to their topology and functioning
(Bullmore and Sporns, 2009). These methods have been used to capture
brain network connectivity during resting state in psychiatric popula-
tions (Baek et al., 2017; Bassett et al., 2008; Luo et al., 2015; Ye et al.,
2015), including those with addiction disorders (Jiang et al., 2013;
Morris et al., 2018; Sjoerds et al., 2017; Tschernegg et al., 2013; Yuan
et al., 2010). These studies, however, have not been able to examine the
characteristics of network functioning during critical psychological
processes known to be disrupted in these populations. Studies ex-
amining connectivity during the psychological processes of cognitive
control (Fornito et al., 2011; Ray et al., 2017) and reward (Manelis
et al., 2016; Nestor et al., 2019; Verdejo-Roman et al., 2017), have been
conducted, providing more precise measures of connectivity across
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networks that relate to these domains. Analytic methods that can reveal
key features of brain network functioning during psychological pro-
cesses may capture disruptions in connectivity that harbour the provi-
sions for relapse risk in addiction disorders, and which may be clinical
targets for medication development.
We have previously shown that abstinent substance-dependent po-
pulations demonstrate regional disturbances during reward processing
(Murphy et al., 2017; Nestor et al., 2017), that likely represent dis-
ruptions in connectivity across global brain networks. This report
documents a novel analytical approach that has attempted to identify
differences in reward-related global network connectivity in an addic-
tion population, an approach that departs from merely attempting to
identify regional disturbances using common voxel-wise analyses. Here
an addiction group in extended abstinence was compared with a control
group on measures of voxel-wise and global network connectivity as-
sociated with reward anticipation on a monetary incentive delay task.
We hypothesized that the addiction group would exhibit whole brain
activation and global network connectivity disturbances, but that
measures of connectivity would prove more sensitive to highlighting
neural disturbances during reward processing in addiction.
2. Material and methods
2.1. Participants
Sixty-eight control (CON: mean age 39.79 ± 1.22; 18 females, 50
males) and 83 addiction (ADD: mean age 40.05 ± 0.92; 16 females, 67
males) participants completed the current study. The current dataset
was collected as part of a multi-centre study involving three study sites
in the United Kingdom (Imperial College London, University of
Cambridge and University of Manchester – ICCAM). For a more detailed
description of the ICCAM Platform, see Paterson et al. (2015) and
McGonigle et al. (2017). Inclusion criteria were individuals who met
DSM-IV measures for current or prior substance dependence (e.g., al-
cohol, cocaine, opiates). The ADD group consisted of 29 (35%) pure
alcohol-dependent, 42 (50%) poly substance-dependent (e.g., alcohol
and cocaine, cocaine and opiate) and 12 (15%) mono substance-de-
pendent (e.g., cocaine, opiates) volunteers. While addiction studies
typically recruit volunteers in early abstinence, there was no upper
limit in the current study. The mean abstinence length from alcohol in
the current sample was 15.00 ± 3.50 months, while for cocaine and
opiates it was 27.99 ± 3.72 and 39.04 ± 7.75 months, respectively.
Therefore, the current ADD group was made of a heterogenous sample
with former substance-dependencies, and with variable levels of sub-
stance abstinence at the time of testing. This meant that there was no
substance dependence measure that was shared by all members of the
ADD group. The CON group had no previous history of substance abuse,
as assessed using the Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST) (Group, 2002) and timeline follow-back. All
participants were required to provide a negative breath alcohol test and
a negative urine sample for various drugs of abuse on the day of testing
(screening for the presence of amphetamines, benzodiazepines, canna-
binoids, cocaine and opiates). The Mini-International Neuropsychiatric
Interview (MINI) (Sheehan et al., 1998) was administered to all parti-
cipants by a trained psychiatrist to screen for the presence of Axis I
psychiatric disorders that were part of the study exclusion criteria.
Exclusion criteria included 1) current use of regular prescription or
non-prescription medication that could not be stopped; 2) current pri-
mary axis I diagnosis, past history of psychosis (unless drug-induced);
3) current or past history of enduring severe mental illness (e.g., schi-
zophrenia, bipolar affective disorder); 4) other current or past psy-
chiatric history that, in the opinion of a psychiatrist, contraindicated
participation; 5) history or presence of a significant neurological diag-
nosis that may have influenced the outcome or analysis of the results; 6)
claustrophobia or unable to lie still in the MRI scanner for up to 90 min
and 7) presence of a cardiac pacemaker, other electronic device or other
MRI contraindication, including pregnancy, as assessed by a standard
pre-MRI questionnaire. Secondary or lifetime history of depression or
anxiety was permitted in both the ADD and CON groups since these are
very common psychiatric disorders.
All participants provided written informed consent. The study was
conducted in accordance with the Declaration of Helsinki. Ethical ap-
proval was obtained from West London and Gene Therapy Advisory
Committee National Research Ethics Service Committee (11/H0707/9)
and relevant research governance and Participant Identification Centre
(PIC) approvals obtained.
3. Monetary incentive delay task (MID)
We used a “monetary incentive delay task” (MID), which was based
on that originally employed by Knutson (Knutson et al., 2001), and
which we have used to already publish data from the ICCAM platform
(Murphy et al., 2017; Nestor et al., 2017). At the beginning of each trial,
participants viewed one of three symbols (a cue) that indicated the
potential to gain fifty pence (square containing an ascending arrow),
lose fifty pence (square containing a descending arrow) or experience
no financial outcome (square containing a horizontal line - here re-
ferred to as a neutral trial). Each cue was presented for one second, with
a variable duration (2–4 s) for the subsequent anticipation period.
Following the anticipation period, participants made a button press
response upon the presentation of a visual target (star located within a
circle). Following their response to the visual target, participants re-
ceived feedback (1.5 s) as to whether they were successful (“Hit”) or
unsuccessful (“Miss”) on that trial and saw a running total of their
winnings up to that point in the task. Following feedback, there was an
end fixation period (3–5 s) before the commencement of the next trial.
Because the primary objective of ICCAM was to examine the neural
correlates of reward anticipation, we chose to use a smaller number of
loss trials in order to amplify the incentive salience of the gain trials
during the task. Consequently, there was a total of 18 gain, 6 lose and
18 neutral trials on each run of the task. The MID task was tailored to
adapt to the visual target reaction time of each participant by using a
staircase algorithm, such that the presentation of the visual target be-
came shorter as performance improved during the experiment. This
enabled us to set a limit on the success rate of each participant (∼66%),
which additionally served to incentivize participants to engage in the
task. Participants were instructed to maximize their winnings and were
told they would receive them at the end of the study. Dependent
measures were accuracy (percentage) and mean reaction time (milli-
seconds) to the visual target on each of the gain, lose and neutral trials,
and the amount won (£) on the task. Participants completed two runs of
the task (432 s each) during scanning. The task was programmed using
E-Prime version 2.0 (Psychology Software Tools, Pittsburgh, USA).
4. Statistics
Group demographics were compared using simple independent
samples t-test analyses. For analyses conducted on MID performance,
two (Group: CON vs. ADD) by two (Condition: Gain vs. Neutral) ana-
lyses of variance were conducted. The CON and ADD groups were also
compared on the lose accuracy and lose reaction time performance
measures, as well as the amount of money won (£), using analyses of
variance. These analyses were conducted controlling for study site. For
the graph measures (see below) we conducted two (Group: CON vs.
ADD) by five (1 ⩽ K ⩽ 5) analyses of variance, while also controlling for
study site. All these analyses were conducted using permutation testing
(5000 iterations) in the R statistical software package (www.R-pro-
ject.org).
5. Functional MRI (fMRI) Data acquisition
The ICCAM platform was designed to allow the rapid testing across
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sites of multiple compounds relevant to addiction treatment. Imaging at
multiple sites in parallel on the ICCAM platform accelerated study
completion, through the sharing of expertise, infrastructure and
capacity. For a more comprehensive description of data acquisition
across the three sites on ICCAM, please see McGonigle et al (McGonigle
et al., 2017). Briefly, all centres operated MRI machines with a main
magnetic field of 3 T (T). Centres in London and Cambridge operated
nominally identical 3 T Siemens Tim Trio systems running the syngo
MR B17 software with a Siemens 32 channel receive-only phased-array
head coil. The Manchester centre operated a 3 T Philips Achieva run-
ning version 2.6.3.5 software and an 8 element SENSE head coil. For
anatomical images, 160 high-resolution T1-weighted anatomic
MPRAGE axial images (FOV 256 mm, thickness 1.0 mm, voxel size
1.0 × 1.0 × 1.0) were acquired (total duration 303 s). Functional data
were acquired using a T2* weighted echo-planar imaging sequence
collecting 36 non-contiguous (0% gap) 3.0 mm axial slices covering the
entire brain (TE = 31 ms, TR = 2000 ms, FOV 225 mm, 64 × 64 mm
matrix size in Fourier space). Each run of the MID task produced a total
of 216 volumes of functional MRI data.
6. fMRI Data analyses
Data pre-processing and statistical analysis were conducted using
FEAT (fMRI Expert Analysis Tool) from the FMRIB Software Library
(www.fmrib.ox.ac.uk/fsl). Pre-statistical processing was as follows:
motion correction utilizing FMRIB’s Linear Image Registration Tool
(MCFLIRT; non-brain matter removal using Brain Extraction Tool
(BET); spatial smoothing with a 5-mm full-width half maximum
Gaussian kernel; mean-based intensity normalization; nonlinear high-
pass temporal filtering (Gaussian-weighted least squares straight line
fit, with sigma = 25.0 s). The six rigid body movement parameters
were also included as regressors in the model in FSL FEAT.
For each participant, first level whole-brain mixed-effects analyses
were performed by modelling the MID anticipation periods (i.e. gain,
neutral) as explanatory variables within the context of the general
linear model on a voxel-by-voxel basis (variable boxcar functions for
the cue + variable anticipation period regressors were convolved with
the haemodynamic response function). The gain and neutral outcome
periods (“Hit” and “Miss”) were regressed out of the functional time
series as conditions of no interest for the analyses reported here. During
these first level analyses, the gain anticipation > neutral anticipation
contrast was formulated. Owing to the small number of loss trials in the
current task, the lose cue + anticipation and outcome periods (“Hit”
and “Miss”) were additionally regressed out of the functional time
series as conditions of no interest. Therefore, the fewer number of lose
trials on the MID task meant we were unable to examine voxel-wise
group differences in loss anticipation. The end fixation period of the
task served as the implicit baseline. Registration was conducted through
a two-step procedure, whereby EPI images were first registered to the
high-resolution T1 structural image, then into standard (Montreal
Neurological Institute, MNI avg152 template) space, with 12-parameter
affine transformations.
Higher-level (within group one-sample t-tests and between-group
independent samples t-tests) were conducted on the gain anticipa-
tion > neutral anticipation contrast using the randomise programme
in FSL (Winkler et al., 2014). Randomise employs a permutation ap-
proach through resampling. Significance (PFWE < 0.05) for the gain
anticipation > neutral anticipation contrast on both the one-sample
and independent samples t-tests was conducted taking a threshold-free
cluster enhancement (TFCE) approach (Smith and Nichols, 2009) and
using 5000 permutations. TFCE aims to maintain the sensitivity of
cluster-based thresholding, while avoiding the arbitrary nature of
threshold choice. Given the differences in scanners across the three
sites, these analyses were conducted while also controlling for study
site.
7. Trial-Wise beta value image analyses
Data pre-processing was also initially conducted using FEAT (fMRI
Expert Analysis Tool) from the FMRIB Software Library (www.fmri-
b.ox.ac.uk/fsl) as described above. For each participant, each in-
dividual gain and neutral anticipation epoch (cue + variable antici-
pation period) was separately modelled within the context of the
general linear model. This approach yielded a total of 18 unique beta
value images for each of the gain and neutral anticipation conditions on
each run of the MID task. This meant that each voxel-wise beta value
image reflected the magnitude of the hemodynamic response evoked by
each of the gain and neutral anticipation epochs. Each beta value image
for each MID run was then subsequently registered into standard (MNI
avg152 template) space before being concatenated to generate a beta
value “trial-wise” (e.g., gain anticipation) time series. Each beta value
trial-wise time series for each MID run was further concatenated across
runs to generate a single beta value trial-wise time series for the gain
and neutral MID anticipation conditions. This procedure yielded a
thirty-six beta value trial-wise time series image for each participant for
the gain and neutral anticipation conditions. The neutral trial-wise time
series was then simply subtracted from the gain trial-wise time series to
yield a gain anticipation > neutral anticipation contrast time series
(see Supplementary Fig. 1). This beta value trial-wise time series
method has been previously used to examine connectivity during cog-
nitive tasks (Fornito et al., 2011; Ray et al., 2017), including the MID
task (Nestor et al., 2019; Verdejo-Roman et al., 2017). The small,
variable (performance-dependent) number of events for the outcome
periods (“hits” and “misses”), and the small number of loss trials in the
task, meant that we could not generate trial-wise beta value images for
these events. Therefore, gain and neutral outcome (well as lose antici-
pation and outcome) events were regressed out of the functional time
series as conditions of no interest during the first level analyses. This
meant that the same end fixation period of the task also served as the
implicit baseline for these analyses.
8. Time series Extraction and correlation matrices
Using the Harvard-Oxford atlas (96 cortical and 14 subcortical
nodes/regions) as our connectome of interest, we used the fslmeants
programme to extract the mean beta value time series from each of 110
anatomical regions of interest (ROI) for the gain anticipation >
neutral contrast beta image for each participant. Using these mean ROI
time series outputs, we then conducted Pearson correlation coefficient
analyses to construct whole brain ROI‐to‐ROI pairwise matrices (see
Supplementary Fig. 1). Each matrix was made up of 5995
(=N*(N − 1)/2, with N = 110 nodes) pairwise connections (edges).
These matrices were generated in MATLAB (The MathWorks, Inc.,
Natick, Massachusetts, United States) and used to compare network
connectivity between the CON and ADD groups (see below).
9. Graph measures
Global (characteristic path length and clustering coefficient) graph
measures were estimated from each correlation matrix using the
GraphVar (www.rfmri.org/GraphVar) toolbox for functional brain
connectivity (Kruschwitz et al., 2015) in MATLAB (The MathWorks,
Inc., Natick, Massachusetts, United States). More detailed descriptions
of brain network graph measures can be found elsewhere (Bullmore and
Sporns, 2009), but we will briefly describe these metrics here. Char-
acteristic path length is the minimum number of edges that must be
traversed to go from one node (brain region) to another in a network.
For a pair of nodes that are nearest neighbours, the path length is 1. The
clustering coefficient, by contrast, quantifies the density of connections
between the nearest neighbour of a node, and describes how segregated
the network is. The path and clustering measures are first estimated at
each node of the connectome before an average (global value) is
L.J. Nestor, et al. NeuroImage: Clinical 27 (2020) 102297
3
computed for the entire connectome for each participant’s correlation
matrix.
Graph measures for each participant were then estimated by
thresholding each matrix at a selection of proportional cost (K)
thresholds – i.e. thresholds that retain only a percentage of the strongest
connections (edges) in the network. Biological networks are re-
presented by sparse connections (Latora and Marchiori, 2003), how-
ever, and thresholding is a necessary step to extract the appropriate
topological properties of networks (Achard and Bullmore, 2007). Be-
cause graph measures can also be sensitive to threshold value (van Wijk
et al., 2010), we have reported our measures across a range of K
thresholds (1 ⩽ K ⩽ 5, increments of 1). Here K represents the per-
centage (e.g., 1 = 10%) number of edges in each matrix that are
maintained following thresholding. We employed a range of thresholds
to represent the lower and upper bound of a small-world system
(Achard and Bullmore, 2007; Bullmore and Bassett, 2011), and that
preserve only the strongest functional connections for efficient parallel
information processing at a relatively low wiring cost (Latora and
Marchiori, 2001). All graph measures were computed from matrices in
their weighted form following this thresholding procedure.
10. Functional connectivity
Group comparisons in ROI‐to‐ROI connectivity across matrices were
assessed using the Networks Based Statistics (NBS) Toolbox (Zalesky
et al., 2010) for MATLAB (The MathWorks, Inc., Natick, Massachusetts,
United States). Comparisons between the CON and ADD groups were
conducted to identify those nodes across the connectome that showed
differences in connectivity. Independent groups t-tests were first per-
formed to test for a between-group difference in the correlation coef-
ficients at each of the 110 × (110–1)/2 = 5995 regional pairings.
Graph sub-components were identified among the connections using a
t-statistic threshold t > 3.1. From here, a family-wise error (FWE)
corrected p-value (p < 0.05) was calculated for the size of each re-
sulting component using permutation testing (5000 permutations). Two
(CON > ADD and ADD > CON) analyses were conducted in-
dependently on the gain anticipation > neutral anticipation contrast
matrices. Given the differences in scanners across the three sites, these
NBS analyses were conducted while controlling for study site. NBS has
previously been used to identify specific networks of nodes across a
connectome that differ between clinical populations during different
psychological processes (Fornito et al., 2011; Nestor et al., 2019; Ray
et al., 2017).
11. Network visualisation
Networks that emerged from group comparisons in NBS were vi-
sualised and presented using brain connectivity maps and circular
connectograms using the NeuroMArVL software (www.immersi-
ve.erc.monash.edu.au/neuromarvl).
12. Results
12.1. Demographics
Table 1 (supplementary section) shows the demographic and sub-
stance use measures for the CON and ADD groups. The groups were
balanced for gender and age, but did significantly differ on other
measures, such as reported education, IQ, anxiety, depression, MINI
score, and the number of participants who were nicotine-dependent.
While we cannot dismiss the potential influence of these demographic
differences on brain activation changes or connectivity during reward
anticipation, we did not use any of these variables as covariates in any
of the analyses reported.
13. MID task
Two (Group: CON vs. ADD) by two (Condition: Gain vs. Neutral)
permutation analyses of variance showed only a significant effect of
condition for MID accuracy (F= 7.8, p < 0.01 - Gain > Neutral) and
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Fig. 1. MID performance results for the CON and ADD group showing a) mean accuracy (**p < 0.01 Gain > Neutral); b) mean reaction time (**p < 0.01
Gain < Neutral); c) mean lose accuracy and d) mean lose reaction time. Data were analysed with permutation analyses of variance (5000 permutations), controlling
for study site. Data are expressed as means and standard error means.
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MID reaction time (F= 8.49, p < 0.01 - Gain < Neutral - Fig. 1a and
b). Permutation analyses did not reveal any significant effect of group
on the MID lose accuracy (F = 0.01, p = 0.94) or reaction time
(F = 0.09, p = 0.77) measures (Fig. 1c and d), or the amount won (£)
on the task (F = 0.45, p = 0.50). These results suggest that the CON
and ADD groups were well matched with respect to MID performance,
while also validating the task with respect to its effects on instrumental
responding for monetary reward.
14. fMRI
One-sample permutation t-test analyses showed that both the CON
and ADD groups activated a mostly frontostriatal network of regions for
gain anticipation > neutral anticipation contrast (TFCE,
PFWE < 0.05) – although these activation changes were weaker in the
ADD group (see Supplementary Fig. 2). Independent samples permu-
tation t-test analyses on the same contrast detected significant differ-
ences between the two groups. The ADD group showed significantly less
activation change compared with the CON group (TFCE, PFWE < 0.05),
particularly across temporal (including the amygdala, hippocampus)
and visual regions. There were also less pronounced differences across
frontal (insula, inferior frontal gyrus) and limbic-associated (anterior
cingulate gyrus, thalamus) regions (Fig. 2). These between groups
analyses, however, did not reveal any differences in activation change
across striatal regions.
15. Graph measures
The results from all permutation tests are provided in the
Supplementary results section. Here we report only the main effects of
Group. Two (Group: CON vs. ADD) by five (1 ⩽ K ⩽ 5) permutation
analyses of variance showed a significant effect of Group on both the
clustering coefficient (F = 29.98, p < 0.001 - ADD < CON) and
characteristic path length (F = 7.30, p < 0.001 – ADD > CON)
measures (Fig. 3a and b).
16. Functional connectivity
The network based statistics (NBS) analyses detected a graph sub-
network comprising 153 edges between 59 nodes of the connectome
where the ADD group demonstrated significantly less connectivity
(p < 0.01) compared with the CON group. These differences in con-
nectivity were mostly intra-hemispheric (55%), the majority (38%)
being in the right hemisphere. The anatomical distribution of these
connectivity differences between the two groups involved frontal (in-
sula, inferior frontal gyrus, orbitofrontal cortex), limbic-associated
(anterior cingulate gyrus, thalamus), visual (lateral occipital cortex,
lingual gyrus, intracalcarine cortex); and unlike the voxel-wise ana-
lyses, striatal (accumbens, caudate, pallidum) regions (Fig. 4).
17. Discussion
We compared a control (CON) and an addiction (ADD) group in
extended abstinence on behavioural and neural measures of a Monetary
Incentive Delay (MID) task. Behaviourally, the two groups were well
matched, enabling us to discount performance as a potential confound
on group differences in brain activation and connectivity. These per-
formance effects showed that both groups were equally incentivized to
maximize monetary gains, as revealed by significant differences be-
tween the gain and neutral conditions. These results, therefore, validate
the incentivizing effects of our MID task on instrumental responding for
rewards. The two groups did, however, show significant differences in
brain activation, and to a greater degree, global network connectivity
related to the anticipation of monetary reward. These differences,
particularly in global connectivity, point to the preservation of wide-
spread neural disturbances in an addiction population, despite being in
extended abstinence.
18. Disruptions to whole brain activation in the ADD group
Here we report that the ADD group showed significantly less acti-
vation change compared with the CON group, most robustly across
temporal and visual cortical regions during the anticipation of mone-
tary reward. Addiction disorders are commonly associated with dis-
turbances in the reward network (Balodis and Potenza, 2015; Hommer
et al., 2011; Just et al., 2019; Koob and Le Moal, 2005; Luijten et al.,
2017; Wrase et al., 2007), and the present results did also show some
evidence for less activation change across reward-associated regions,
the most pronounced of which were in the anterior cingulate gyrus
(ACG) and amygdala. Disturbances in ACG functioning have been
commonly reported in addiction populations (Goldstein and Volkow,
2002; Peoples, 2002; Volkow et al., 2002), which persist into ab-
stinence (Bolla et al., 2004; Eldreth et al., 2004; Nestor et al., 2011;
Nestor et al., 2017; Salloum et al., 2007). The differences observed in
the current sample were within the dorsal ACG, a region implicated in
motivation and cognitive control (Kouneiher et al., 2009). The amyg-
dala also encodes stimulus value (Jenison et al., 2011), with disruptions
also evident in addiction (Lesscher and Vanderschuren, 2012; See et al.,
2003). These results point to localised neural disturbances in regions
implicated in motivational, executive functioning and reward evalua-
tion, that endure into extended abstinence.
This current set of results, however, was in the absence of group
-12 -2 8 18 28 38
ADD < CON
PFWE <0.05
R
Fig. 2. Permutation independent samples t-test analyses showing that ADD < CON group activation differences on the MID gain anticipation > neutral antici-
pation contrast. Images were produced after 5000 permutations in randomise using TFCE (PFWE < 0.05), controlling for study site. The bar corresponds to
PFWE < 0.05 and lower. The structural image represents the MNI152 average normal brain with corresponding horizontal coordinates (inferior–superior). R = right
hemisphere.
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differences in striatal activation between the ADD and CON groups.
This does not appear to concur with previous research findings of al-
tered striatal responses for non-drug rewards in substance dependence
(Buhler et al., 2010; Bustamante et al., 2014; Diekhof et al., 2008;
Gradin et al., 2014; Murphy et al., 2017; Nestor et al., 2017; Peters
et al., 2011; Wrase et al., 2007), and does not demonstrate evidence of a
sustained striatal “reward deficiency syndrome” (Blum et al., 2000;
Koob et al., 2004) in this particular sample. The heterogenous nature of
the ADD sample with respect to mono- and multiple- drug dependencies
and the variable abstinence length from these substances, may have
been a constraining factor, reflecting varying levels of restoration of
function in the striatum (and other regions). For example, studies have
shown there are deficits in markers of striatal dopamine functioning
during early abstinence (Boileau et al., 2016; Martinez et al., 2005;
Wang et al., 2012), with the variable abstinence length in the current
sample masking possible disturbances in this region. Another possibility
is that a voxel-wise approach was insufficiently sensitive to detect
group differences across smaller regions such as the striatum. The re-
sults from the network analyses (discussed below) did reveal striatal
regions (e.g., accumbens, caudate) that were part of a sub-network of
Fig. 3. Global network differences between groups showing a) clustering (***p < 0.001, ADD < CON) and b) path length (**p < 0.01, ADD > CON) during the
gain > neutral contrast of the MID task. Data were analysed using two (group: CON vs. ADD) × five (1 ⩽ K ⩽ 5) permutation anova analyses, controlling for study
site. Data are expressed as means and standard error means.
 
a) b)
Fig. 4. Non-parametric network based statistics (NBS) analysis results showing a graph sub-component comprising 153 edges (p < 0.01) where the ADD group
demonstrated significantly less connectivity compared to the CON group during the gain > neutral anticipation contrast of the MID task. Graph sub-components
were identified among all node pairwise connections with a t-statistic threshold of t > 3.1, corrected for multiple comparisons, while controlling for study site using
permutation (5000) analyses. Reductions in connectivity in the ADD group are represented by a) brain connectivity maps and b) a circular connectogram. Brain
regions are grouped on the connectogram circumference according to lobes and centres in the left and right hemispheres (left frontal [dark blue]; left temporal [light
blue]; left parietal [dark orange], left occipital [light orange]); left limbic [dark green]; right frontal [light green]; right temporal [dark red]; right parietal [pink];
right occipital [dark purple]; right limbic [light purple]; left striatal [dark brown] and right striatal [light brown]. Brain connectivity maps and the circular
connectogram were generated using NeuroMArVL (http://immersive.erc.monash.edu.au/neuromarvl). (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
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nodes demonstrating less connectivity in the ADD group. This may
further endorse the sensitivity of exploring measures of functional
network connectivity over voxel-wise approaches for detecting more
extensive disruptions in neural processing. Finally, it is possible that the
ADD and CON groups simply did not differ in the striatum, which has
recently been shown in other studies of stimulant users (e.g. Just et al.,
2019).
19. Disruptions in global network connectivity in the ADD group
The ADD group had an increased mean global characteristic path
length compared to the CON group. As described above, path length is a
topological measure indicating the average shortest path length be-
tween all node pairs in a network, whereby fewer processing steps
across the network has the advantage of propagating more rapid and
accurate communication (Kaiser and Hilgetag, 2006). We observed this
metric to be elevated in the ADD group, representing a possible re-
duction in processing efficiency. This may be due to a loss of long range
connections between remote brain regions, which are critical for
minimising path lengths and maintaining network efficiency. This dis-
ruption in processing efficiency concurs with that reported in other
addiction populations during rest (Holla et al., 2017; Lin et al., 2015;
Morris et al., 2018; Wang et al., 2015), but not during reward proces-
sing (Nestor et al., 2019).
We further report that the ADD group demonstrated a lower clus-
tering coefficient across the network. Clustering quantifies the number
of connections existing between a node’s nearest neighbours, which has
been proposed as an index of local specialised processing and economic
pressure for minimal wiring cost (Bullmore and Bassett, 2011; Kaiser
and Hilgetag, 2006; Rubinov and Sporns, 2010; Sporns et al., 2004).
The reduction in clustering we report here contrasts with the increased
clustering found in an addiction population during resting state, and
which was reversed by acute naltrexone (Morris et al., 2018). Altera-
tions in clustering observed during reward anticipation may suggest
less interconnectedness in local networks for specialised or segregated
information processing, which could be more economically costly for
brain functioning (Bullmore and Sporns, 2012). Significantly, these
global functional alterations could be due to changes in anatomical
network architecture, as functional connectivity is generally tightly
aligned with anatomical connectivity (Honey et al., 2009; Sporns, 2011;
van den Heuvel et al., 2009).
20. Decreased reward-related connectivity in the ADD group
Taking a network based statistics (NBS) analysis approach, we
showed that the ADD group exhibited reduced connectivity across a
sub-network of nodes during the anticipation of reward. This reduction
in connectivity comprised a total of 153 connections, the majority of
which were confined to the right hemisphere. The anatomical dis-
tribution of these between-group connectivity differences involved
frontal (insula, inferior frontal gyrus, orbitofrontal cortex), striatal
(accumbens, caudate), limbic-associated (ACG, amygdala, hippo-
campus) and visual (lateral occipital cortex, lingual gyrus, in-
tracalcarine cortex) regions. Similar analysis approaches have also re-
vealed differences across sub-networks in addiction, however, during
resting state (Hong et al., 2013; Morris et al., 2018; Wee et al., 2014).
The connectivity differences reported in this ADD sample indicate al-
terations between cognitive, striatal and limbic-associated regions
during reward anticipation that persist into extended abstinence. Fur-
thermore, the emergence of a more extensive network of regions in this
connectivity analysis highlights a more sensitive approach for detecting
widespread disruptions across neural networks in addiction, that may
fail to emerge through conventional voxel-wise analysis approaches.
The presence of these connectivity differences across a distributed
sub-network of nodes, concomitant with differences on global topolo-
gical measures, is also noteworthy. Previous studies using combined
graph- and network-based approaches have failed to report differences
using both types of measures (Cocchi et al., 2012; Fornito et al., 2011;
Hong et al., 2013). While topological and network-based measures of
connectivity may be distinct, there does appear to be some convergence
across both analyses that suggests the preservation of functional dis-
ruptions in a latent and more widespread network in this addiction
group.
21. Conclusion
The spatial distribution of functional disturbances reported in ad-
diction populations during functional MRI studies is commonplace, and
is likely driven by extensive disruptions in connectivity across the
whole brain network. The current study, taking a novel analytical ap-
proach, has revealed reward-related functional alterations across a
global network in an addiction disorder population who are in extended
abstinence. These differences in connectivity feature in the presence of
more localised activation disruptions that emerge from a conventional
voxel-wise analytic approach. We propose that examining measures of
global network functioning may be more sensitive for highlighting la-
tent and more widespread disruptions to neural functioning during
critical psychological processes in addiction and other psychiatric dis-
orders. Alterations in functioning across global networks could act as
markers for relapse risk during abstinence, that may be potential targets
for medication development in addiction disorders.
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